Neurogene (NGNE) Treasury Shares (2013 - 2023)

Neurogene (NGNE) has 9 years of Treasury Shares data on file, last reported at $252124.0 in Q1 2026.

• Quarterly Treasury Shares changed 0.0% year-over-year to $252124.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $252124.0 (changed 0.0% YoY) and the FY2025 annual result came in at $256361.0, up 1.68% from the prior year.
• Treasury Shares eased to $252124.0 in Q1 2026, from $256361.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $18.6 million in Q3 2023 to a low of $252124.0 in Q4 2024.
• A 5-year average of $4.4 million and a median of $465931.5 in 2022 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2023 — Treasury Shares surged 3995.69% — and 2024, when it plunged 97.43%.
• Tracing NGNE's Treasury Shares over 5 years: stood at $13.3 million in 2022, then jumped by 39.98% to $18.6 million in 2023, then plunged by 98.64% to $252124.0 in 2024, then grew by 1.68% to $256361.0 in 2025, then retreated by 1.65% to $252124.0 in 2026.
• The last three Treasury Shares figures came in at $252124.0 (Q1 2026), $256361.0 (Q4 2025), and $252124.0 (Q3 2025), per Business Quant data.